Knee Distraction Shows Promise in Severe Osteoarthritis

Knee osteoarthritis, a degenerative joint condition, carries significant global prevalence, often stemming from inflammatory joint processes, trauma, occupational stress, and obesity. While total knee arthroplasty effectively alleviates pain and restores function, its limited lifespan and increased revision risk in younger patients necessitate alternative joint-preserving strategies. Emerging evidence highlights the potential of approaches such as Knee Joint Distraction (KJD), High Tibial Osteotomy (HTO), platelet-rich plasma therapy, and radiofrequency ablation in managing knee OA. These non-invasive and joint-preserving interventions have demonstrated efficacy in reducing OA-related pain and improving patient outcomes.^1,2

The fundamental challenge in managing severe knee OA, especially in younger, active individuals, lies in balancing immediate pain relief and functional restoration with the long-term durability of the intervention. TKA, while highly effective, typically has a lifespan of 15-20 years, meaning younger recipients often require revision surgery, which carries increased risks and complexities. This unmet need drives the search for therapies that can preserve the native joint for as long as possible. KJD, by temporarily separating the joint surfaces, aims to reduce mechanical loading, promote cartilage regeneration, and alleviate pain, thereby offering a biological rather than prosthetic solution.^1,2

What the trials actually measured

A meta-analysis published in the Malaysian Orthopaedic Journal by Tan, Angeles, and Braganza in 2025 directly compared patient-reported and structural outcomes of Knee Joint Distraction (KJD) against High Tibial Osteotomy (HTO) and Total Knee Arthroplasty (TKA). The analysis included studies evaluating these interventions for knee OA, focusing on their efficacy in pain reduction and functional improvement. The authors sought to provide a comprehensive overview of these joint-preserving and joint-replacing strategies, particularly in the context of their suitability for younger patients.¹

The meta-analysis synthesized data from multiple studies, allowing for a broader assessment of comparative effectiveness. It included studies that reported on patient-reported outcome measures (PROMs) such as the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, as well as structural outcomes like joint space width (JSW) or cartilage regeneration. The patient populations across the included studies typically comprised individuals with moderate to severe knee OA, often those who had failed conservative management but were not yet considered ideal candidates for TKA due to age or activity level. The primary goal was to determine if KJD could offer comparable benefits to more established surgical options.¹

The meta-analysis found that KJD provided comparable improvements in patient-reported outcomes to both HTO and TKA. Specifically, KJD demonstrated similar reductions in WOMAC pain, stiffness, and physical function scores. While specific numerical comparisons (e.g., mean differences or standardized mean differences) were not detailed in the provided abstract, the conclusion of comparable efficacy is clear. This suggests that KJD can achieve similar levels of pain relief and functional improvement as more invasive surgical procedures, without the permanent alteration of the joint structure inherent in TKA or the bone cutting involved in HTO.¹

Structural outcomes also supported KJD's utility. The meta-analysis indicated that KJD could lead to improvements in joint space width or evidence of cartilage regeneration, suggesting a disease-modifying effect. This is a critical distinction from symptomatic treatments, positioning KJD as a therapy that may slow or even reverse some aspects of OA progression. HTO also aims for structural correction by realigning the joint, but KJD achieves its structural benefits through a different biological mechanism, primarily by de-loading the joint and promoting anabolic processes within the cartilage.¹

A separate clinical and radiological study by Huizinga, de Vries, and Jansen, published in Knee in 2025, further explored KJD, comparing it against a custom-made unloading orthosis for knee osteoarthritis. This study provided a direct comparison of a mechanical intervention (orthosis) with a biological-mechanical intervention (KJD). The patient cohort for this study also consisted of individuals with knee OA, likely those with varus or valgus malalignment who could benefit from unloading strategies. The investigators aimed to assess both the symptomatic relief and any structural changes induced by each intervention.²

The Huizinga study found that KJD demonstrated superior clinical and radiological outcomes compared to the custom-made unloading orthosis. While the abstract does not provide specific metrics, it states KJD showed efficacy in reducing OA-related pain and improving patient outcomes. This suggests that the temporary distraction of the joint, which allows for biological repair processes, is more effective than simply offloading the joint with an external device. The radiological findings likely included measures of joint space, subchondral bone changes, or other markers of OA progression, where KJD presumably showed more favorable results than the orthosis.²

The mechanism behind KJD's efficacy involves several factors. By creating a temporary gap between the articular surfaces, KJD reduces the compressive forces that contribute to cartilage degradation in OA. This reduction in load can alleviate pain immediately. Critically, the distraction also creates a low-pressure environment within the joint, which is thought to stimulate chondrocyte activity and promote the synthesis of new cartilage matrix components. This biological response, often termed 'chondrogenesis,' is what differentiates KJD from purely mechanical interventions and offers the potential for long-term joint preservation. The duration of distraction, typically several weeks, is crucial for these regenerative processes to take hold.^1,2

But the practical application of KJD involves an external fixation device, which patients wear for an extended period. This can impact patient comfort, mobility, and daily activities. While the meta-analysis concluded comparable outcomes to TKA and HTO, the patient experience during the treatment phase differs significantly. TKA offers immediate, albeit invasive, relief and functional restoration. HTO also involves a recovery period from surgery. KJD, while joint-preserving, requires patient compliance with the external fixator and careful management to prevent complications such as pin-site infections or nerve irritation. The commitment required from patients for KJD is substantial, and this must be weighed against the benefits of joint preservation.¹

The studies did not explicitly detail the long-term durability of KJD compared to TKA or HTO beyond the immediate follow-up periods. While KJD aims to delay TKA, the exact duration of this delay and the factors predicting successful long-term outcomes remain areas for further investigation. The meta-analysis, by its nature, synthesizes existing data, but the heterogeneity of study designs, patient populations, and follow-up durations across the included trials could introduce variability in the overall findings. The specific criteria for patient selection for KJD, such as OA severity, alignment, and age, are also critical for optimizing outcomes, and these were not exhaustively detailed in the provided abstracts.^1,2

Still, the consistent message from both the meta-analysis and the comparative study is that KJD is a viable and effective treatment option for knee OA, particularly for patients seeking to avoid or postpone total joint replacement. Its ability to not only alleviate symptoms but also potentially induce structural improvements positions it as a significant advancement in joint-preserving strategies. The evidence suggests that KJD should be considered alongside HTO and TKA in the treatment algorithm for appropriate patients, offering a less invasive, yet equally effective, alternative for managing severe knee osteoarthritis.^1,2